Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 112
Filtrar
1.
Biologicals ; 55: 27-37, 2018 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-30078661

RESUMO

Proteus mirabilis is one of the important pathogens of urinary tract and exhibits resistance to multiple drugs. Development of vaccine tends to be the most promising and cost-effective remedy against the said pathogen. Herein, we implement a combinatorial approach for screening proteins harboring potential broad-spectrum antigenic epitopes in the proteome of P. mirabilis. The targets are host non-homologous, essential and virulent, and have localization in the extracellular and outer membrane. Immuno-informatics revealed antigenic, surface exposed and broad-spectrum B-cell derived T-cell epitopes for three membrane usher family candidates: AtfC, PMI2533 and PMI1466, which could evoke a substantial immune response. Protein-protein interactions of targeted three proteins have shown their involvement in biologically significant pathways indispensable for the growth and survival of the pathogen. The antigenic epitopes are conserved among all completely annotated strains and docked deeply in the binding cavity of the most prevalent allele-DRB1*0101 in human population. Future work is necessary to characterize the shortlisted proteins and epitopes for immune protection in animal models.


Assuntos
Proteínas da Membrana Bacteriana Externa/química , Vacinas Bacterianas/química , Farmacorresistência Bacteriana Múltipla , Epitopos/química , Cadeias HLA-DRB1/química , Proteoma/química , Proteínas da Membrana Bacteriana Externa/imunologia , Vacinas Bacterianas/imunologia , Epitopos/imunologia , Cadeias HLA-DRB1/imunologia , Humanos , Simulação de Acoplamento Molecular , Proteoma/imunologia , Proteus vulgaris/química , Proteus vulgaris/imunologia
2.
Genet Mol Res ; 14(3): 10619-29, 2015 Sep 09.
Artigo em Inglês | MEDLINE | ID: mdl-26400293

RESUMO

Biofilm-forming bacteria are highly resistant to antibiotics, host immune defenses, and other external conditions. The formation of biofilms plays a key role in colonization and infection. To explore the mechanism of biofilm formation, mutant strains of Proteus vulgaris XC 2 were generated by Tn5 random transposon insertion. Only one biofilm defective bacterial species was identified from among 500 mutants. Inactivation of the glpC gene coding an anaerobic glycerol-3-phosphate dehydrogenase subunit C was identified by sequence analysis of the biofilm defective strain. Differences were detected in the growth phenotypes of the wild-type and mutant strains under pH, antibiotic, and organic solvent stress conditions. Furthermore, we observed an increase in the phagocytosis of the biofilm defective strain by the mouse macrophage RAW264.7 cell line compared to the wild-type strain. This study shows that the glpC gene plays an important role in biofilm formation, in addition to imparting pH, organic solvent, and antibiotic tolerance, and defense against phagocytosis to Proteus sp. The results further clarified the mechanism of biofilm formation at the genomic level, and indicated the importance of the glpC gene in this process. This data may provide innovative therapeutic measures against P. vulgaris infections; furthermore, as an important crocodile pathogen, this study also has important significance in the protection of Chinese alligators.


Assuntos
Proteínas de Bactérias/genética , Biofilmes/crescimento & desenvolvimento , Glicerolfosfato Desidrogenase/genética , Infecções por Proteus/veterinária , Proteus vulgaris/genética , Proteus vulgaris/imunologia , Adaptação Fisiológica/imunologia , Jacarés e Crocodilos/microbiologia , Animais , Proteínas de Bactérias/imunologia , Biofilmes/efeitos dos fármacos , Linhagem Celular , Cicloexanos/farmacologia , Elementos de DNA Transponíveis , Escherichia coli/genética , Escherichia coli/metabolismo , Expressão Gênica , Glicerolfosfato Desidrogenase/imunologia , Hexanos/farmacologia , Concentração de Íons de Hidrogênio , Evasão da Resposta Imune , Macrófagos/microbiologia , Camundongos , Mutação , Infecções por Proteus/microbiologia , Infecções por Proteus/patologia , Proteus vulgaris/efeitos dos fármacos , Proteus vulgaris/isolamento & purificação , Proteínas Recombinantes/genética , Proteínas Recombinantes/imunologia
3.
Microbiology (Reading) ; 159(Pt 6): 1036-1043, 2013 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-23579689

RESUMO

The O-polysaccharide was isolated by mild acid hydrolysis of the lipopolysaccharide of Proteus vulgaris HSC 438, and the following structure was established by chemical methods and one- and two-dimensional (1)H and (13)C NMR spectroscopy: →3)-ß-d-Quip4NAlo-(1→3)-α-d-Galp6Ac-(1→6)-α-d-Glcp-(1→3)-α-l-FucpNAc-(1→3)-ß-d-GlcpNAc-(1→, where d-Qui4N stands for 4-amino-4,6-dideoxy-d-glucose and Alo for N-((S)-1-carboxyethyl)-l-alanine (alanopine); only about half of the Gal residues are O-acetylated. This structure is unique among the Proteus O-polysaccharides, and therefore it is proposed to classify P. vulgaris HSC 438 into a new Proteus serogroup, O76. A serological cross-reactivity of HSC 438 O-antiserum and lipopolysaccharides of some other Proteus serogroups was observed and accounted for by shared epitopes on the O-polysaccharides or lipopolysaccharide core regions, including that associated with d-Qui4NAlo.


Assuntos
Alanina/análogos & derivados , Lipopolissacarídeos/imunologia , Antígenos O/química , Proteus vulgaris/química , Proteus vulgaris/imunologia , Alanina/análise , Reações Cruzadas , Dados de Sequência Molecular , Antígenos O/imunologia , Proteus vulgaris/classificação , Sorotipagem
4.
Artigo em Russo | MEDLINE | ID: mdl-20799399

RESUMO

AIM: Assessment of clinical and immunological effects of use of bacterial therapeutic polycomponent vaccine Immunovac-VP4 for allergen-specific immunotherapy (ASIT) of hay fever. MATERIALS AND METHODS: Five doses of Immunovac-VP4 vaccine consisted of antigens of opportunistic bacteria was used and administered by nasal-oral route. ASIT was performed with standard water-saline solution of allergens according to defined schedule. Sixty-nine patients with season rhinoconjunctivitis, asthma and their combinations were included in the study and divided to two groups. Skin scarification test was performed, total level of serum IgE, IgG4 and IgE to pollen allergens were measured by ELISA. Also, questionnaire was sent to patients yearly. RESULTS: Administration of bacterial therapeutic vaccine Immunovac-VP4 before start of ASIT resulted in marked clinical and immunological effect. In group of patients receiving combination therapy compared to control group, 8.5 times lower incidence of acute respiratory infections was registered. According to results of analysis of patients' questionnaires after 7 years, effectiveness of therapy was 90% that points to achievement of prolonged remission after completion of ASIT course. CONCLUSION: Utilization of natural ligands of Toll-like receptors is a perspective direction for development of new immunotherapeutic strategies for treatment of allergic diseases.


Assuntos
Vacinas Bacterianas/administração & dosagem , Dessensibilização Imunológica , Rinite Alérgica Sazonal/terapia , Administração Intranasal , Administração Oral , Adolescente , Adulto , Alérgenos/efeitos adversos , Antialérgicos/uso terapêutico , Antígenos de Bactérias/imunologia , Vacinas Bacterianas/imunologia , Criança , Pré-Escolar , Escherichia coli/imunologia , Humanos , Esquemas de Imunização , Klebsiella pneumoniae/imunologia , Proteus vulgaris/imunologia , Rinite Alérgica Sazonal/etiologia , Rinite Alérgica Sazonal/imunologia , Staphylococcus aureus/imunologia , Resultado do Tratamento , Vacinas Combinadas/administração & dosagem , Vacinas Combinadas/imunologia
5.
Artigo em Russo | MEDLINE | ID: mdl-21381375

RESUMO

AIM: Assessment of prophylactic effect of Immunovac-VP-4 against acute respiratory diseases (ARDs) in collectives of children. MATERIALS AND METHODS: Immunovac-VP-4 was used for prophylaxis of ARDs in communities of children (daycare centers, boarding school). During 3 consecutive controlled studies performed during peak incidence of epidemic influenza and ARD (1st study) and during pre-epidemic period (2nd and 3rd studies) the incidence of ARDs was studied in groups of vaccinated and non-vaccinated children. Criteria for assessment of ARDs incidence and their severity were as follows: number of ARD episodes per child, number of children with recurrent episodes of ARD during period of follow-up, duration of ARDs, and number of children with bacterial complications (bronchitis, otitis, etc.). Effect of intervention on immunologic parameters was assessed on levels of sIgA, IgG, IgA, and antibody titers in saliva. Schedule of vaccine administration was 3 daily intranasal and 6 - 9 oral administration of the vaccine with 3 - 4 days interval. RESULTS: Results of all three studies were virtually the same: decrease of number of ARD episodes and their duration; 3.1-fold reduction of number of children with recurrent infections during 14 months of follow-up, and 10.9--12-fold reduction during first 7 months of follow-up; decrease of bacterial complications rate (1.9% in children in intervention group, 11.9%--in control group). Increase of total immunoglobulin level and antibody titers to antigenic components of the vaccine from low baseline level was observed in saliva of vaccinated children. CONCLUSION: Immunovac-VP-4 results in enhanced and prolonged prophylactic effect on ARDs incidence and recommended for building of optimal system of prevention of polyetiologic complex of ARDs.


Assuntos
Antígenos de Bactérias/administração & dosagem , Fatores Imunológicos/administração & dosagem , Infecções Respiratórias/prevenção & controle , Vacinação , Doença Aguda , Administração Intranasal , Administração Oral , Anticorpos Antibacterianos/análise , Antígenos de Bactérias/imunologia , Criança , Creches , Pré-Escolar , Escherichia coli/imunologia , Humanos , Imunoglobulina A/análise , Imunoglobulina A Secretora/análise , Imunoglobulina G/análise , Fatores Imunológicos/imunologia , Klebsiella pneumoniae/imunologia , Proteus vulgaris/imunologia , Infecções Respiratórias/imunologia , Saliva/imunologia , Staphylococcus aureus/imunologia
6.
Klin Lab Diagn ; (7): 22-4, 33, 2009 Jul.
Artigo em Russo | MEDLINE | ID: mdl-19718822

RESUMO

An antigen similar to the autoagglutination factor (AF) of plague pathogen in immunochemical specificity was sought in 22 bacterial species. For this, an immunoglobulin anti-AF diagnosticum that is the sheep erythrocytes sensitized with rabbit immune serum to the AF preparation isolated from the plasmid-free variant of the Yersinia pestis strain EV76. The bacteriological study applying a passive hemagglutination assay revealed AF-like antigens not only in all study strains (n = 30) of Y. pestis, but also in Yersinia pseudotuberculosis, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Proteus vulgaris. These bacteria were used to prepare AF = like antigen preparations that reacted with rabbit anti-AF serum in dot blot immunoassay. Also, as Y. pestis, AF-like antigens in polyacrylamide gel were detected as multiple protein bands that differed in mobility in Yersiniae and heterologous bacteria. Differences were found in the properties of AF-line antigens of 5 species of bacteria (sensitivity to temperature and formalin, binding to the cell surface, which enabled differentiation of serological reactions caused by AP-like antigens of other bacteria. Thus, Y. pestis AF is a cross-reacting antigen that, despite its immunochemical similarity with AF-like antigens of other bacteria, was ascertained to differ from them in properties. The findings are of interest for searching for new diagnostic tests to detect the Cafl- strains of the plague pathogen and for differentiating the causative organisms of plague and pseudotuberculosis.


Assuntos
Aglutinação/imunologia , Antígenos de Bactérias/imunologia , Peste/diagnóstico , Yersinia pestis/imunologia , Proteínas de Bactérias/imunologia , Diagnóstico Diferencial , Testes de Hemaglutinação , Humanos , Klebsiella pneumoniae/imunologia , Peste/microbiologia , Proteus vulgaris/imunologia , Pseudomonas aeruginosa/imunologia , Yersinia pestis/isolamento & purificação , Yersinia pseudotuberculosis/imunologia , Infecções por Yersinia pseudotuberculosis/diagnóstico , Infecções por Yersinia pseudotuberculosis/microbiologia
7.
Arch Immunol Ther Exp (Warsz) ; 55(3): 187-91, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-17557147

RESUMO

INTRODUCTION: Proteus rods are currently subdivided into five named species, i.e. Proteus mirabilis, P. vulgaris, P. penneri, P. hauseri, and P. myxofaciens, and three unnamed Proteus genomospecies 4 to 6. Based on the serospecificity of the lipopolysaccharide (LPS; O-antigen), strains of P. mirabilis and P. vulgaris were divided into 49 O-serogroups and 11 additional O-serogroups were proposed later. About 15 further O-serogroups have been proposed for the third medically important species, P. penneri. Here the serological classification of P. vulgaris strain TG 251, which does not belong to these serogroups, is reported. Serological investigations also allowed characterization of the epitope specificity of its LPS. MATERIALS AND METHODS: Purified LPSs from five Proteus strains were used as antigens in enzyme immunosorbent assay (EIA), SDS/PAGE, and Western blot and alkali-treated LPSs in the passive immunohemolysis (PIH) test, inhibition of PIH and EIA, and absorption of the rabbit polyclonal O-antisera with the respective LPS. RESULTS: The serological studies of P. vulgaris TG 251 LPS indicated the identity of its O-polysaccharide with that of P. penneri O65. The antibody specificities of P. vulgaris TG 251 and P. penneri O65 O-antisera, were described. CONCLUSIONS: P. vulgaris TG 251 was classified to the Proteus O65 serogroup. Two disaccharide-associated epitopes present in P. vulgaris TG 251 and P. penneri O65 LPSs are suggested to be responsible for cross-reactions with three heterologous Proteus strains.


Assuntos
Lipopolissacarídeos/imunologia , Antígenos O/imunologia , Proteus vulgaris/classificação , Proteus vulgaris/imunologia , Sorotipagem , Animais , Antígenos de Bactérias , Reações Cruzadas , Epitopos/química , Epitopos/imunologia , Lipopolissacarídeos/química , Lipopolissacarídeos/isolamento & purificação , Antígenos O/química , Proteus penneri/classificação , Proteus penneri/imunologia , Proteus penneri/isolamento & purificação , Proteus vulgaris/isolamento & purificação
8.
FEMS Immunol Med Microbiol ; 47(2): 267-74, 2006 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-16831214

RESUMO

O-Polysaccharides were obtained from the lipopolysaccharides of Proteus mirabilis CCUG 10704 (OE) and Proteus vulgaris TG 103 and studied by chemical analyses and one- and two-dimensional (1)H and (13)C nuclear magnetic resonance spectroscopy, including rotating-frame nuclear Overhauser effect spectroscopy, H-detected (1)H,(13)C heteronuclear single-quantum spectroscopy and (1)H,(31)P heteronuclear multiple-quantum spectroscopy experiments. The Proteus mirabilis OE polysaccharide was found to have a trisaccharide repeating unit with a lateral glycerol phosphate group. The Proteus vulgaris TG 103 produces a similar O-polysaccharide, which differs in incomplete substitution with glycerol phosphate (c. 50% of the stoichiometric amount) and the presence of an O-acetyl group at position 6 of the 2-acetamido-2-deoxygalactose (GalNAc) residue. These structures are unique among the known bacterial polysaccharide structures. Based on the structural and serological data of the lipopolysaccharides, it is proposed to classify both strains studied into a new Proteus serogroup, O54, as two subgroups, O54a,54b and O54a,54c. The serological relatedness of the Proteus O54 and some other Proteus lipopolysaccharides is discussed.


Assuntos
Lipopolissacarídeos/química , Antígenos O/química , Polissacarídeos Bacterianos/química , Proteus mirabilis/metabolismo , Proteus vulgaris/metabolismo , Sequência de Carboidratos , Mapeamento de Epitopos , Lipopolissacarídeos/imunologia , Dados de Sequência Molecular , Ressonância Magnética Nuclear Biomolecular , Antígenos O/imunologia , Polissacarídeos Bacterianos/imunologia , Proteus mirabilis/imunologia , Proteus vulgaris/imunologia
9.
Arch Immunol Ther Exp (Warsz) ; 54(4): 277-82, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-16868723

RESUMO

INTRODUCTION: Bacteria of the genus Proteus are facultative pathogens which commonly cause urinary tract infections. Based on the serological specificity of the O-chain polysaccharide of the lipopolysaccharide (O-polysaccharide, O-antigen), strains of P. mirabilis and P. vulgaris have been classified into 60 serogroups. Studies on the chemical structure and serological specificity of the O-antigens aim at the elucidation of the molecular basis and improvement of the serological classification of these bacteria. MATERIALS AND METHODS: The O-polysaccharide was prepared by acetic acid degradation of the lipopolysaccharide isolated from dried bacterial mass of each strain by hot phenol/water extraction. (1)H- and (13)C-NMR spectroscopy was used for structural studies. Serological studies were performed with rabbit O-antisera using enzyme immunosorbent assay, passive hemolysis test, and the inhibition of reactions in these assays as well DOC-PAGE and Western blot. RESULTS: Four Proteus strains belonging to serogroups O17 and O35 were found to possess similar O-polysaccharide structures, in particular having the same carbohydrate backbone built up of tetrasaccharide repeating units. However, they differ in the presence or absence of additional substituents, such as phosphoethanolamine in P. mirabilis O17 and glucose in P. penneri O17, as well as in the pattern and degree of O-acetylation of various monosaccharide residues. Serological studies also showed close relationships between the O-antigens studied. CONCLUSIONS: Based on these data it is proposed to reclassify strain P. mirabilis PrK 61/57, formerly representing the O35 serogroup, into the serogroup O17 in the Kauffman-Perch classification system of Proteus.


Assuntos
Antígenos O/química , Proteus mirabilis/classificação , Proteus vulgaris/classificação , Configuração de Carboidratos , Sequência de Carboidratos , Espectroscopia de Ressonância Magnética , Dados de Sequência Molecular , Proteus mirabilis/química , Proteus vulgaris/química , Proteus vulgaris/imunologia , Sorotipagem
10.
Arch Immunol Ther Exp (Warsz) ; 54(3): 223-6, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-16736109

RESUMO

INTRODUCTION: Gram-negative bacteria of the genus Proteus from the family Enterobacteriaceae are currently divided into the five species P. mirabilis, P. vulgaris, P. penneri, P. hauseri, and P. myxofaciens and three unnamed Proteus genomospecies 4, 5, and 6. They are important facultative human and animal pathogens which, under favorable conditions, cause mainly intestinal and urinary tract infections, sometimes leading to serious complications such as acute or chronic pyelonephritis and the formation of bladder and kidney stones. In this study we report on the serological properties of the lipopolysaccharide (LPS) of P. mirabilis TG 276-90, whose O-polysaccharide chemical structure was described earlier. MATERIALS AND METHODS: LPS and alkali-treated LPS of a few serologically related Proteus strains and O-antisera against P. mirabilis TG 276-90 and CCUG 4669 (O34) were used. Serological characterization of P. mirabilis TG 276-90 O-specific polysaccharide was done using enzyme immunosorbent assay, passive immunohemolysis test (PIH), inhibition of these tests, SDS/PAGE and Western blot techniques, absorption of rabbit polyclonal O-antisera, and repeated PIH test. RESULTS: Structural and serological investigations showed that the O-polysaccharides of P. mirabilis TG 276-90 and P. vulgaris O34 are identical and that their LPSs differ only in epitopes in the core part. Therefore these two strains could be classified into the same Proteus O34 serogroup. CONCLUSIONS: The serological data showed that the beta-D-GalpNAc-(1--> 4)-alpha-D-GalpNAc disaccharide is an important epitope of the P. mirabilis TG 276-90 and P. vulgaris O34 LPSs, shared by the P. mirabilis O16 and P. vulgaris TG 251 LPSs. It is responsible for cross-reactions with P. mirabilis TG 276-90 and P. vulgaris O34 O-antisera.


Assuntos
Antígenos O/imunologia , Proteus mirabilis/imunologia , Proteus vulgaris/imunologia , Sequência de Carboidratos , Reações Cruzadas , Dissacarídeos/química , Dissacarídeos/imunologia , Epitopos/química , Epitopos/imunologia , Dados de Sequência Molecular , Antígenos O/química , Antígenos O/isolamento & purificação , Proteus mirabilis/química , Proteus mirabilis/classificação , Proteus vulgaris/química , Proteus vulgaris/classificação , Sorotipagem
11.
Artigo em Russo | MEDLINE | ID: mdl-15346948

RESUMO

A complex of clinical and laboratory examinations of patients with bacterial chronic prostatitis was carried out. The patients were divided into two groups: 55 patients treated by the method of immunotherapy and 20 patients (controls) undergoing basic therapy. Immunotherapy was carried out with the use of polycomponent vaccine VP-4 containing Staphylococcus aureus, Klebsiella pneumoniae, Proteus vulgaris and Escherichia coli antigens. Vaccinal therapy was indicated in cases with infection focus associated with opportunistic bacteria, a prolonged torpid course of prostatitis and when different schemes of etiotropic therapy proved to be ineffective. The vaccine was introduced in 4 or 5 subcutaneous injections at an interval of 5-7 days. The study revealed that in cases of chronic prostatitis accompanied by microecological and immune disturbances the use of complex therapy allowed to achieve good clinical and laboratory results in 91% of the patients. In the patients undergoing immunotherapy the elimination of opportunistic bacteria from the urogenital tract and the restoration of affected microflora occurred.


Assuntos
Vacinas Bacterianas/uso terapêutico , Escherichia coli/imunologia , Imunoterapia Ativa , Klebsiella pneumoniae/imunologia , Prostatite/terapia , Proteus vulgaris/imunologia , Staphylococcus aureus/imunologia , Adulto , Vacinas Bacterianas/administração & dosagem , Doença Crônica , Humanos , Esquemas de Imunização , Injeções Subcutâneas , Masculino , Pessoa de Meia-Idade , Próstata/microbiologia , Prostatite/microbiologia , Vacinas Combinadas , Vacinas de Subunidades Antigênicas/administração & dosagem , Vacinas de Subunidades Antigênicas/uso terapêutico
12.
Artigo em Russo | MEDLINE | ID: mdl-15636137

RESUMO

Bacterial polycomponent vaccine (VP-4) earlier developed at the Mechnikov Research Institute for Vaccines and Sera on the basis of antigenic complexes of Klebsiella pneumoniae, Proteus vulgaris, Escherichia coli, Staphylococcus aureus was used within the program of clinical trials, for the treatment of 30 patients aged 16-59 years with the atopic and mixed form of bronchial asthma and chronic obstructive bronchitis by the combined naso-subcutaneous application. A good therapeutic effect produced by the vaccine was registered in 83.3% of the patients. It was manifested by a lower frequency of acute respiratory diseases and bronchopulmonary diseases as well as decreased need in antibiotic therapy. In the group of comparison a good effect was noted in 40% of the patients during 6 months of observation (statistically significant difference). Side effects caused by the administration of the vaccine were transitory, had mainly local character and disappeared without any treatment. In 1 patient the development of anaphylactic shock was observed. The positive effect of vaccine VP-4 could be attributed to the improved indices of cell-mediated immunity, an increased synthesis of alpha- and gamma-interferon, a droped level of IgE and specific IgG antibodies to Staphylococcus sp., Klebsiella sp., Proteus sp., Escherichia coli.


Assuntos
Asma/terapia , Vacinas Bacterianas/uso terapêutico , Bronquite Crônica/terapia , Administração Intranasal , Adolescente , Adulto , Anafilaxia/etiologia , Anticorpos Antibacterianos/sangue , Especificidade de Anticorpos , Antígenos de Bactérias/imunologia , Asma/sangue , Vacinas Bacterianas/efeitos adversos , Bronquite Crônica/sangue , Esquema de Medicação , Escherichia coli/imunologia , Feminino , Humanos , Injeções Subcutâneas , Interferon-alfa/sangue , Interferon gama/sangue , Klebsiella pneumoniae/imunologia , Masculino , Pessoa de Meia-Idade , Proteus vulgaris/imunologia , Staphylococcus aureus/imunologia , Vacinas Combinadas/efeitos adversos , Vacinas Combinadas/uso terapêutico
13.
Carbohydr Res ; 338(13): 1425-30, 2003 Jun 23.
Artigo em Inglês | MEDLINE | ID: mdl-12801716

RESUMO

The O-polysaccharide (O-antigen) of Providencia alcalifaciens O21 was obtained by mild acid degradation of the lipopolysaccharide and studied by chemical methods and NMR spectroscopy. It was found that the polysaccharide is built up of branched pentasaccharide repeating units with a terminal residue of 3-formamido-3,6-dideoxy-D-galactose (D-Fuc3NFo) and has the following structure: [structure: see text]. Anti-P. alcalifaciens O21 serum cross-reacted with the O-antigen of Proteus vulgaris O47, which contains a GalNAc trisaccharide similar to that present in the P. alcalifaciens O21 O-polysaccharide.


Assuntos
Antígenos O/química , Oligossacarídeos de Cadeias Ramificadas/química , Providencia/química , Acetilgalactosamina/análise , Amino Açúcares/análise , Sequência de Carboidratos , Reações Cruzadas/imunologia , Ácidos Hexurônicos/análise , Espectroscopia de Ressonância Magnética , Dados de Sequência Molecular , Oligossacarídeos de Cadeias Ramificadas/imunologia , Proteus vulgaris/química , Proteus vulgaris/imunologia
14.
Arch Immunol Ther Exp (Warsz) ; 51(1): 69-74, 2003.
Artigo em Inglês | MEDLINE | ID: mdl-12691306

RESUMO

Analysis by 1H and 13C nuclear magnetic resonance (NMR) spectroscopy demonstrated that the O-specific polysaccharides of Proteus mirabilis PrK 42/57 and P. vulgaris PrK 43/57 are structurally similar to that of P. vulgaris PrK 44/57 and different from the polysaccharide of P. mirabilis PrK 41/57 studied earlier. The lipopolysaccharides of these strains were tested using enzyme immunosorbent assay, passive hemolysis and Western blot with O-antisera against P. mirabilis 42/57 and P. vulgaris 43/57 and 44/57, as well as with cross-absorbed O-antisera. The chemical and serological data revealed the basis for combining the four strains into Proteus serogroup O23 and division of this serogroup to three subgroups, one for P. vulgaris 43/57 and 44/57 and two others for P. mirabilis 41/57 and 42/57.


Assuntos
Antígenos O/química , Antígenos O/imunologia , Proteus mirabilis/química , Proteus vulgaris/química , Animais , Configuração de Carboidratos , Sequência de Carboidratos , Ensaio de Imunoadsorção Enzimática , Ressonância Magnética Nuclear Biomolecular , Proteus mirabilis/imunologia , Proteus vulgaris/imunologia
15.
J Med Microbiol ; 52(Pt 4): 303-308, 2003 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-12676868

RESUMO

The bactericidal activity of human neutrophils against extracellular and facultatively intracellular bacteria was studied in the presence of the nitric oxide (NO) donors sodium nitroprusside (SNP) and 3-morpholinosydnonimine (SIN-1), a molsidomine metabolite. SNP and molsidomine are drugs commonly used as nitrovasodilators in coronary heart disease. It is demonstrated here that the NO donor compounds themselves did not affect the viability and survival of the bacterial strains tested. Neither SNP nor SIN-1 had any effect on the process of bacteria ingestion. In contrast, NO donors enhanced the ability of neutrophils to kill Escherichia coli, Proteus vulgaris and Salmonella Anatum. However, strains differed in their susceptibility to SNP- and SIN-1-mediated killing by neutrophils. Removal of the superoxide anion reduced the bactericidal activity of SNP- and SIN-1-treated neutrophils against E. coli and S. Anatum. This suggests that the NO derivatives formed in the reaction of NO generated from donors with the reactive oxygen species released by phagocytosed neutrophils potentiate the bactericidal activity of human neutrophils in vitro. The above original observation discussed here suggests clinical significance for the treatment of patients with nitrovasodilators in the course of coronary heart disease therapy.


Assuntos
Molsidomina/análogos & derivados , Molsidomina/farmacologia , Neutrófilos/fisiologia , Doadores de Óxido Nítrico/farmacologia , Óxido Nítrico/metabolismo , Nitroprussiato/farmacologia , Escherichia coli/imunologia , Humanos , Molsidomina/metabolismo , Neutrófilos/efeitos dos fármacos , Doadores de Óxido Nítrico/metabolismo , Nitritos/metabolismo , Nitroprussiato/metabolismo , Fagocitose/efeitos dos fármacos , Proteus vulgaris/imunologia , Espécies Reativas de Oxigênio/metabolismo , Salmonella enterica/imunologia
16.
FEMS Immunol Med Microbiol ; 31(3): 227-34, 2001 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-11720819

RESUMO

The O-specific polysaccharide (O-antigen) of the lipopolysaccharide (LPS) of Proteus vulgaris O37 was studied by (1)H and (13)C nuclear magnetic resonance spectroscopy before and after O-deacetylation and found to be structurally similar to that of P. vulgaris O46 studied earlier. The two polysaccharides have the same carbohydrate backbone and differ in the position and number of the O-acetyl groups only. Studies with O-antisera against the two strains using passive hemolysis test, enzyme immunosorbent assay, and Western blot revealed close serological relatedness of the LPSs of P. vulgaris O37 and O46. The O-acetyl groups were found to be of little importance for manifesting the O-specificity but to interfere with binding of anti-P. vulgaris O37 serum to P. vulgaris O46 antigen. Based on the data obtained, it was proposed to combine the strains studied in one Proteus serogroup O37 as subgroups O37a,37b and O37a,37c. A cross-reactivity of O-antisera against P. vulgaris O37 and O46 was observed with LPSs of three more Proteus strains, which could be substantiated by the presence of a common disaccharide fragment in the O-antigens.


Assuntos
Lipopolissacarídeos/imunologia , Antígenos O/química , Proteus vulgaris/imunologia , Configuração de Carboidratos , Sequência de Carboidratos , Ensaio de Imunoadsorção Enzimática , Hemólise , Lipopolissacarídeos/química , Espectroscopia de Ressonância Magnética , Dados de Sequência Molecular , Antígenos O/imunologia , Proteus vulgaris/química , Proteus vulgaris/classificação
19.
Biochemistry (Mosc) ; 65(9): 1055-9, 2000 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-11042498

RESUMO

An acidic O-specific polysaccharide was obtained by mild acid degradation of the lipopolysaccharide of the bacterium Proteus vulgaris O23 (strain PrK 44/57) and found to contain 2-acetamido-2-deoxy-D-galactose, 2-acetamido-2-deoxy-D-glucose, and D-galacturonic acid. Based on 1H- and 13C-NMR spectroscopic studies, including two-dimensional correlation spectroscopy (COSY), total correlation spectroscopy (TOCSY), nuclear Overhauser effect spectroscopy (NOESY), and 1H,13C heteronuclear multiple-quantum coherence (HMQC) experiments, the following structure of the branched tetrasaccharide repeating unit of the polysaccharide was established: [figure], where the degree of O-acetylation of the terminal GalA residue at position 4 is about 80%. A structural similarity of the O-specific polysaccharides of P. vulgaris O23 and P. mirabilis O23 is discussed.


Assuntos
Antígenos O/química , Polissacarídeos/química , Proteus vulgaris/química , Acetilação , Sequência de Carboidratos , Cromatografia Gasosa , Espectroscopia de Ressonância Magnética , Dados de Sequência Molecular , Antígenos O/isolamento & purificação , Proteus vulgaris/imunologia
20.
Eur J Biochem ; 267(3): 788-93, 2000 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-10651815

RESUMO

A phosphorylated O-specific polysaccharide (O-antigen) was obtained by mild acid degradation of Proteus vulgaris O12 lipopolysaccharide and studied by sugar and methylation analyses, 1H-, 13C- and 31P-NMR spectroscopy, including two-dimensional COSY, TOCSY, NOESY, H-detected 1H, 13C and 1H, 31P heteronuclear multiple-quantum coherence experiments. It was found that the polysaccharide consists of pentasaccharide repeating units connected via a glycerol phosphate group, and has the following structure: where FucNAc is 2-acetamido-2,6-dideoxygalactose and the degree of O-acetylation at position 4 of GalNAc is approximately 25%. Immunochemical studies with P. vulgaris O12 O-antiserum suggested that the lipopolysaccharide studied shares common epitopes with the lipopolysaccharide core of P. vulgaris O8 and with the O-antigens of P. penneri strains 8 and 63.


Assuntos
Antígenos O/química , Proteus vulgaris/química , Proteus vulgaris/imunologia , Animais , Anticorpos Antibacterianos , Configuração de Carboidratos , Sequência de Carboidratos , Reações Cruzadas , Glicerol/química , Imunoquímica , Espectroscopia de Ressonância Magnética , Dados de Sequência Molecular , Proteus/química , Proteus/imunologia , Coelhos , Especificidade da Espécie , Ácidos Teicoicos/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA